{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T07:36:54Z","timestamp":1793777814322,"version":"4.6.1"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jconrel.2026.114931","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T07:01:51Z","timestamp":1776322911000},"page":"114931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Electric fields to enhance drug delivery to non-superficial tumors"],"prefix":"10.1016","volume":"395","author":[{"given":"Nidda","family":"Saeed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"Coene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieke","family":"Adriaens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Ceelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.114931_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188792","article-title":"Interstitial fluid pressure as an emerging biomarker in solid tumors","volume":"1877","author":"Salavati","year":"2022","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.114931_bb0010","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.trecan.2025.05.003","article-title":"The extracellular matrix in cancer: from understanding to targeting","volume":"11","author":"Chitty","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jconrel.2026.114931_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107958","article-title":"Hyaluronic acid and its role in pancreatic cancer: mechanisms of tumor progression, drug resistance, and therapeutic targeting","volume":"221","author":"Cai","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2026.114931_bb0020","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.addr.2013.05.010","article-title":"Physical energy for drug delivery; poration, concentration and activation","volume":"71","author":"Lakshmanan","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.114931_bb0025","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1053\/apmr.2001.25905","article-title":"A historical perspective of the popular use of electric and magnetic therapy","volume":"82","author":"Basford","year":"2001","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.jconrel.2026.114931_bb0030","series-title":"Wiley Encyclopedia of Biomedical Engineering","author":"Miklav\u010di\u010d","year":"2026"},{"key":"10.1016\/j.jconrel.2026.114931_bb0035","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1088\/0031-9155\/41\/11\/001","article-title":"The dielectric properties of biological tissues: I. Literature survey","volume":"41","author":"Gabriel","year":"1996","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.jconrel.2026.114931_bb0040","series-title":"CRC Handbook of Biological Effects of Electromagnetic Fields","first-page":"27","article-title":"Dielectric properties of tissues","author":"Foster","year":"2019"},{"key":"10.1016\/j.jconrel.2026.114931_bb0045","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.plrev.2022.09.003","article-title":"The distinguishing electrical properties of cancer cells","volume":"43","author":"Di Gregorio","year":"2022","journal-title":"Phys Life Rev"},{"key":"10.1016\/j.jconrel.2026.114931_bb0050","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/1759-7714.12605","article-title":"Dielectric properties for non-invasive detection of normal, benign, and malignant breast tissues using microwave theories","volume":"9","author":"Cheng","year":"2018","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.jconrel.2026.114931_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/bios14080382","article-title":"Electrical conductivity measurement in human liver tissue: assessment on normal vs. tumor tissue and under in vivo vs. ex vivo conditions","volume":"14","author":"Sarreshtehdari","year":"2024","journal-title":"Biosensors"},{"key":"10.1016\/j.jconrel.2026.114931_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioelechem.2024.108821","article-title":"Measurement and comparison of dielectric properties of human pancreatic tumours, healthy tissues and porcine tissues ex vivo between 1Hz and 1MHz","volume":"161","author":"Le Berre","year":"2025","journal-title":"Bioelectrochemistry"},{"key":"10.1016\/j.jconrel.2026.114931_bb0065","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1088\/0031-9155\/57\/17\/5425","article-title":"Treatment planning of electroporation-based medical interventions: electrochemotherapy, gene electrotransfer and irreversible electroporation","volume":"57","author":"Zupanic","year":"2012","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.jconrel.2026.114931_bb0070","series-title":"Electrotechnologies for Extraction From Food Plants and Biomaterials","first-page":"1","article-title":"Electroporation in biological cell and tissue: an overview","author":"Kandu\u0161er","year":"2008"},{"key":"10.1016\/j.jconrel.2026.114931_bb0075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1475-925X-13-29","article-title":"Electrochemotherapy: from the drawing board into medical practice","volume":"13","author":"Miklav\u010di\u010d","year":"2014","journal-title":"Biomed. Eng. Online"},{"key":"10.1016\/j.jconrel.2026.114931_bb0080","unstructured":"Baumgartner, C. et al. (IT'IS Foundation, Zurich, Switzerland, 2025)."},{"key":"10.1016\/j.jconrel.2026.114931_bb0085","doi-asserted-by":"crossref","first-page":"14TR01","DOI":"10.1088\/1361-6560\/ac7b64","article-title":"Measurement and image-based estimation of dielectric properties of biological tissues\u2014past, present, and future\u2014","volume":"67","author":"Sasaki","year":"2022","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.jconrel.2026.114931_bb0090","doi-asserted-by":"crossref","DOI":"10.1115\/1.4064746","article-title":"Current status and emerging techniques for measuring the dielectric properties of biological tissues","volume":"3","author":"Porter","year":"2024","journal-title":"ASME Open J. Eng."},{"key":"10.1016\/j.jconrel.2026.114931_bb0095","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0168-3659(99)00132-7","article-title":"Iontophoresis: Electrorepulsion and electroosmosis","volume":"64","author":"Guy","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114931_bb0100","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0022-3565(25)31970-1","article-title":"Increased penetration of nonelectrolytes into mouse skin during iontophoretic water transport (iontohydrokinesis)","volume":"212","author":"Gangarosa","year":"1980","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2026.114931_bb0105","doi-asserted-by":"crossref","first-page":"10504","DOI":"10.1073\/pnas.90.22.10504","article-title":"Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery","volume":"90","author":"Prausnitz","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.114931_bb0110","series-title":"Electrochemical Methods: Fundamentals and Applications","author":"Bard","year":"2022"},{"key":"10.1016\/j.jconrel.2026.114931_bb0115","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0169-409X(92)90022-I","article-title":"Transdermal ion migration","volume":"9","author":"Bradley Phipps","year":"1992","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.114931_bb0120","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/jps.2600671031","article-title":"Conductivity of drugs used for iontophoresis","volume":"67","author":"Gangarosa","year":"1978","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.114931_bb0125","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/jps.20757","article-title":"Iontophoretic drug delivery across human nail","volume":"96","author":"Murthy","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.114931_bb0130","series-title":"Handbook of Physical Medicine and Rehabilitation","article-title":"Electrical stimulation and iontophoresis","author":"Stillwell","year":"1971"},{"key":"10.1016\/j.jconrel.2026.114931_bb0135","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0165-0270(87)80004-3","article-title":"Quantification of angiotensin iontophoresis","volume":"19","author":"Harding","year":"1987","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.jconrel.2026.114931_bb0140","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/jps.2600780505","article-title":"Iontophoretic delivery model inorganic and drug ions","volume":"78","author":"Phipps","year":"1989","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.114931_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0168-3659(88)90075-2","article-title":"Iontophoretic delivery of drugs: fundamentals, developments and biomedical applications","volume":"7","author":"Banga","year":"1988","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114931_bb0150","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.addr.2003.10.026","article-title":"Iontophoretic drug delivery","volume":"56","author":"Kalia","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.114931_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118619","article-title":"Feasibility and efficacy of electromotive intraperitoneal drug delivery: a hybrid study","volume":"192","author":"Saeed","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2026.114931_bb0160","first-page":"875","article-title":"Electromotive delivery of mitomycin c into human bladder wall","volume":"57","author":"Di Stasi","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2026.114931_bb0165","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.2309","article-title":"Investigation of the mechanisms of action behind electromotive drug administration (EMDA)","volume":"4","author":"Kos","year":"2016","journal-title":"PeerJ"},{"key":"10.1016\/j.jconrel.2026.114931_bb0170","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/end.2023.0418","article-title":"Electromotive drug administration in the porcine renal pelvis: first report","volume":"38","author":"Sharifi","year":"2024","journal-title":"J. Endourol."},{"key":"10.1016\/j.jconrel.2026.114931_bb0175","first-page":"823","article-title":"Electromotive drug administration in the ureter in an in vivo animal model: initial report","volume":"37","author":"Sharifi","year":"2023","journal-title":"J. Endourol."},{"key":"10.1016\/j.jconrel.2026.114931_bb0180","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11255-023-03765-0","article-title":"Device-assisted intravesical chemotherapy versus bacillus Calmette-Guerin for intermediate or high-risk non-muscle invasive bladder cancer: a systematic reviewer and meta-analysis","volume":"56","author":"You","year":"2024","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.jconrel.2026.114931_bb0185","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/01.ju.0000080568.91703.18","article-title":"Intravesical electromotive mitomycin c versus passive transport mitomycin c for high risk superficial bladder cancer: a prospective randomized study","volume":"170","author":"Di Stasi","year":"2003","journal-title":"J. Urol."},{"key":"10.1016\/j.jconrel.2026.114931_bb0190","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4111\/icu.20230161","article-title":"The effect of immediate neoadjuvant electromotive instillation of mitomycin c with bacillus Calmette-Gu\u00e9rin versus BCG alone in non-muscle-invasive bladder cancer: a randomized controlled trial","volume":"64","author":"El Azab","year":"2023","journal-title":"Investig. Clin. Urol."},{"key":"10.1016\/j.jconrel.2026.114931_bb0195","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S1470-2045(11)70190-5","article-title":"Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial","volume":"12","author":"Di Stasi","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jconrel.2026.114931_bb0200","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/17425247.2020.1736551","article-title":"Intraperitoneal chemotherapy for peritoneal metastases: an expert opinion","volume":"17","author":"Ceelen","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.114931_bb0205","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1073\/pnas.1600421113","article-title":"Iontophoretic device delivery for the localized treatment of pancreatic ductal adenocarcinoma","volume":"113","author":"Byrne","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.114931_bb0210","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00280-018-3570-3","article-title":"Impact of formulation on the iontophoretic delivery of the FOLFIRINOX regimen for the treatment of pancreatic cancer","volume":"81","author":"Byrne","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.114931_bb0215","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009951","article-title":"Local iontophoretic administration of cytotoxic therapies to solid tumors","volume":"7","author":"Byrne","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.114931_bb0220","article-title":"A decade of iontronic delivery devices","volume":"3","author":"Arbring Sj\u00f6str\u00f6m","year":"2018","journal-title":"Adv. Mater. Technol."},{"key":"10.1016\/j.jconrel.2026.114931_bb0225","article-title":"Targeted chemotherapy of glioblastoma spheroids with an iontronic pump","volume":"6","author":"Waldherr","year":"2021","journal-title":"Adv. Mater. Technol."},{"key":"10.1016\/j.jconrel.2026.114931_bb0230","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jconrel.2024.03.044","article-title":"Continuous iontronic chemotherapy reduces brain tumor growth in embryonic avian in vivo models","volume":"369","author":"Handl","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114931_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/admt.202301641","article-title":"Redox flow iontophoresis for continuous drug delivery","volume":"9","author":"Naegele","year":"2024","journal-title":"Adv. Mater. Technol."},{"key":"10.1016\/j.jconrel.2026.114931_bb0240","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1148\/radiol.2020192190","article-title":"High-voltage electrical pulses in oncology: irreversible electroporation, electrochemotherapy, gene electrotransfer, electrofusion, and electroimmunotherapy","volume":"295","author":"Geboers","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.jconrel.2026.114931_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14174341","article-title":"Electrochemotherapy: an alternative strategy for improving therapy in drug-resistant solid tumors","volume":"14","author":"Condello","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2026.114931_bb0250","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bioelechem.2018.06.010","article-title":"Cell membrane electroporation modeling: a multiphysics approach","volume":"124","author":"Goldberg","year":"2018","journal-title":"Bioelectrochemistry"},{"key":"10.1016\/j.jconrel.2026.114931_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059557","article-title":"Differential mechanisms associated with vascular disrupting action of electrochemotherapy: intravital microscopy on the level of single normal and tumor blood vessels","volume":"8","author":"Markelc","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2026.114931_bb0260","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jconrel.2018.02.032","article-title":"Increased permeability of blood vessels after reversible electroporation is facilitated by alterations in endothelial cell-to-cell junctions","volume":"276","author":"Markelc","year":"2018","journal-title":"J. Controll Release"},{"key":"10.1016\/j.jconrel.2026.114931_bb0265","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jconrel.2021.03.009","article-title":"Potentiation of electrochemotherapy effectiveness by immunostimulation with IL-12 gene electrotransfer in mice is dependent on tumor immune status","volume":"332","author":"Ursic","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114931_bb0270","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1080\/0284186X.2018.1454602","article-title":"Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases","volume":"57","author":"Gehl","year":"2018","journal-title":"Acta Oncol."},{"key":"10.1016\/j.jconrel.2026.114931_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10061305","article-title":"Clinical phase I\/II study: local disease control and survival in locally advanced pancreatic cancer treated with electrochemotherapy","volume":"10","author":"Izzo","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jconrel.2026.114931_bb0280","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s13304-020-00782-x","article-title":"Intraoperative electrochemotherapy in locally advanced pancreatic cancer: indications, techniques and results-a single-center experience","volume":"72","author":"Casadei","year":"2020","journal-title":"Updat. Surg."},{"key":"10.1016\/j.jconrel.2026.114931_bb0285","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ijsu.2015.04.055","article-title":"Electrochemotherapy in locally advanced pancreatic cancer: preliminary results","volume":"18","author":"Granata","year":"2015","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.jconrel.2026.114931_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioelechem.2023.108576","article-title":"Intraoperative electrochemotherapy of the posterior resection surface after pancreaticoduodenectomy: preliminary results of a hybrid approach treatment of pancreatic cancer","volume":"155","author":"\u010cebron","year":"2024","journal-title":"Bioelectrochemistry"},{"key":"10.1016\/j.jconrel.2026.114931_bb0295","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10174011","article-title":"A multicenter randomized controlled prospective study to assess efficacy of laparoscopic electrochemotherapy in the treatment of locally advanced pancreatic cancer","volume":"10","author":"Izzo","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jconrel.2026.114931_bb0300","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2478\/raon-2022-0003","article-title":"Percutaneous electrochemotherapy in primary and secondary liver malignancies - local tumor control and impact on overall survival","volume":"56","author":"Spallek","year":"2022","journal-title":"Radiol. Oncol."},{"key":"10.1016\/j.jconrel.2026.114931_bb0305","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.ejso.2020.04.037","article-title":"Intraoperative electrochemotherapy of colorectal liver metastases: a prospective phase II study","volume":"46","author":"Edhemovic","year":"2020","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.jconrel.2026.114931_bb0310","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ejso.2018.01.090","article-title":"Electrochemotherapy as treatment option for hepatocellular carcinoma, a prospective pilot study","volume":"44","author":"Djokic","year":"2018","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.jconrel.2026.114931_bb0315","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijsu.2017.06.033","article-title":"Safety and feasibility of electrochemotherapy in patients with unresectable colorectal liver metastases: a pilot study","volume":"44","author":"Coletti","year":"2017","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.jconrel.2026.114931_bb0320","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000027730","article-title":"A case report of cryoablation and electrochemotherapy in kidney cancer","volume":"100","author":"Mastrandrea","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jconrel.2026.114931_bb0325","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00270-020-02498-2","article-title":"Reversible electrochemotherapy (ECT) as a treatment option for local RCC recurrence in solitary kidney","volume":"43","author":"Andresciani","year":"2020","journal-title":"Cardiovasc. Intervent. Radiol."},{"key":"10.1016\/j.jconrel.2026.114931_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12094-024-03551-z","article-title":"Tumor-treating fields in cancer therapy: advances of cellular and molecular mechanisms","volume":"27","author":"Xiao","year":"2025","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.jconrel.2026.114931_bb0335","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41420-018-0130-x","article-title":"Tumor treating fields increases membrane permeability in glioblastoma cells","volume":"4","author":"Chang","year":"2018","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.jconrel.2026.114931_bb0340","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1038\/s41598-020-59445-x","article-title":"Barium titanate nanoparticles sensitise treatment-resistant breast cancer cells to the antitumor action of tumour-treating fields","volume":"10","author":"Yoon","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.114931_bb0345","doi-asserted-by":"crossref","DOI":"10.1007\/s10143-026-04155-7","article-title":"Impact of tumor treating fields on overall and progression-free survival in newly diagnosed glioblastoma: a systematic review and meta-analysis","volume":"49","author":"Shah","year":"2026","journal-title":"Neurosurg. Rev."},{"key":"10.1016\/j.jconrel.2026.114931_bb0350","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1200\/JCO-25-00746","article-title":"Tumor treating fields with gemcitabine and nab-paclitaxel for locally advanced pancreatic adenocarcinoma: randomized, open-label, pivotal phase III PANOVA-3 study","volume":"43","author":"Babiker","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.114931_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115306","article-title":"Tumor treating fields therapy in platinum-resistant ovarian cancer: results of the ENGOT-ov50\/GOG-3029\/INNOVATE-3 pivotal phase 3 randomized study","volume":"219","author":"Vergote","year":"2025","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jconrel.2026.114931_bb0360","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1001\/jama.2017.18718","article-title":"Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial","volume":"318","author":"Stupp","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jconrel.2026.114931_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107244","article-title":"Modeling and ex vivo evaluation of electrostatic precipitation-enhanced intraperitoneal aerosol drug delivery","volume":"213","author":"Rahimi-Gorji","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.114931_bb0370","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202000655","article-title":"Electrostatic intraperitoneal aerosol delivery of nanoparticles: proof of concept and preclinical validation","volume":"9","author":"Van de Sande","year":"2020","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.114931_bb0375","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.actbio.2023.08.027","article-title":"The effect of electrostatic high pressure nebulization on the stability, activity and ex vivo distribution of ionic self-assembled nanomedicines","volume":"170","author":"Braet","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2026.114931_bb0380","article-title":"Electromodulation of human monocyte-derived macrophages drives a regenerative phenotype and impedes inflammation","volume":"6","author":"O\u2019Rourke","year":"2025","journal-title":"Cell Rep. Phys. Sci."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926003342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926003342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T09:24:18Z","timestamp":1781256258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926003342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":76,"alternative-id":["S0168365926003342"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114931","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Electric fields to enhance drug delivery to non-superficial tumors","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114931","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114931"}}